Track market-moving stories before they get noisy

The upcoming report from Dynatrace (DT - Free Report) is expected to reveal quarterly earnings of $0.39 per share, indicating an increase of 18.2% compared to the year-ago period. Analysts forecast revenues of $520.64 million, representing an increase of 17% year over year.

Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

Bearing this in mind, let's now explore the average estimates of specific Dynatrace metrics that are commonly monitored and projected by Wall Street analysts.

According to the collective judgment of analysts, 'Revenues- Services' should come in at $24.72 million. The estimate indicates a year-over-year change of +14.5%.

Analysts forecast 'Revenues- Subscriptions' to reach $495.94 million. The estimate points to a change of +17.1% from the year-ago quarter.

Analysts expect 'Annual Recurring Revenue (ARR)- Total' to come in at $2.06 billion. Compared to the current estimate, the company reported $1.73 billion in the same quarter of the previous year.

View all Key Company Metrics for Dynatrace here>>>

Shares of Dynatrace have experienced a change of +19.4% in the past month compared to the +11% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), DT is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

BOSTON--(BUSINESS WIRE)--Dynatrace (NYSE: DT), the leading AI-powered observability platform, today announced financial results for the fourth quarter and full year ended March 31, 2026.

"Dynatrace delivered a strong finish to FY26, surpassing $2 billion in ARR and achieving our fourth consecutive quarter of 16% constant currency ARR growth,” said Rick McConnell, CEO of Dynatrace. “In an AI‑first world, observability has become mission critical to a vastly higher percentage of workloads. Customers are choosing Dynatrace for our end‑to‑end platform, which serves as both the intelligence engine for deterministic AI and contextual analytics, as well as the control plane to coordinate agentic action. By enabling system resilience and AI reliability, Dynatrace is helping customers drive more autonomous operations and optimal business outcomes. As we look ahead, our objective is to accelerate ARR growth while delivering balanced growth and profitability."

“We significantly increased the pace of our share buyback in the fourth quarter, repurchasing $224 million of Dynatrace stock,” said Jim Benson, Chief Financial Officer. “This uptick reflects our conviction in Dynatrace’s operational momentum, long term growth and cash flow trajectory, and the underlying value of our shares. Through our disciplined capital allocation approach and strong balance sheet, we will continue investing in innovation and growth while delivering value to shareholders.”

All growth rates are compared to the fourth quarter and full year fiscal 2025 ended March 31, 2025 unless otherwise noted.

Fourth Quarter Fiscal 2026 Financial Highlights:

Total ARR of $2,054 million, an increase of 18%, or 16% on a constant currency basis Total revenue of $532 million, an increase of 19%, or 16% on a constant currency basis Subscription revenue of $506 million, an increase of 19%, or 16% on a constant currency basis GAAP income from operations of $37 million and non-GAAP income from operations of $143 million GAAP net income per share of $0.06 and non-GAAP net income per share of $0.41, on a dilutive basis Full Year Fiscal 2026 Financial Highlights:

Total revenue of $2,018 million, an increase of 19%, or 17% on a constant currency basis Subscription revenue of $1,930 million, an increase of 19%, or 17% on a constant currency basis GAAP income from operations of $245 million and non-GAAP income from operations of $592 million GAAP net income per share of $0.54 and non-GAAP net income per share of $1.70, on a dilutive basis GAAP operating cash flow of $562 million and free cash flow of $529 million Business Highlights:

Ongoing traction in go-to-market strategy resulted in an increase in average deal size. Dynatrace closed a record 22 deals greater than $1 million in annual contract value (ACV) in the fourth quarter, nine of which were new logos. Log management remained the fastest growing major product category, with Q4 consumption continuing to grow more than 100% year-over-year. Enhanced the company's offerings through two acquisitions: DevCycle, a feature management platform on the OpenFeature standard that helps developers, site reliability engineers, and platform teams bring progressive delivery for AI-native applications directly into the Dynatrace platform. Bindplane, a company whose open-standards-based telemetry pipeline capabilities combined with AI-powered observability gives customers greater access, flexibility, and control of their logs, metrics, and application data. Surpassed $1 billion in AWS Marketplace sales, a key indicator of hyperscaler engagement. Expanded the Dynatrace Model Context Protocol (MCP) server as a connector for Anthropic's Claude Code, Cowork, and Chat to bring observability and security context into every Claude session. And extended integration with GitHub Advanced Security to share the runtime context of monitored Kubernetes environments with developers and security teams. Recognized as a Customers’ Choice in the 2025 Gartner Peer Insights Voice of the Customer for Observability Platforms report.1 Share Repurchase Program

During the fourth quarter of fiscal 2026, Dynatrace spent $224 million to repurchase 5.9 million shares at an average price of $37.71. Dynatrace completed its initial $500 million share repurchase program, and $151 million of purchases in the fourth quarter were under its new $1 billion program announced in February 2026. Fourth Quarter 2026 Financial Highlights

(Unaudited – In thousands, except per share data)

  Three Months Ended March 31,

2026

2025

Annual recurring revenue (ARR):

Total ARR

$

2,053,555

$

1,734,164

Year-over-Year Increase

18

%

Year-over-Year Increase - constant currency (*)

16

%

Revenue:

Total revenue

$

531,716

$

445,165

Year-over-Year Increase

19

%

Year-over-Year Increase - constant currency (*)

16

%

Subscription revenue

$

505,754

$

423,570

Year-over-Year Increase

19

%

Year-over-Year Increase - constant currency (*)

16

%

GAAP Financial Measures:

GAAP income from operations

$

37,342

$

42,914

GAAP operating margin

7

%

10

%

GAAP net income

$

17,416

$

39,304

GAAP net income per share - diluted

$

0.06

$

0.13

GAAP shares outstanding - diluted

298,925

304,354

Net cash provided by operating activities

$

226,361

$

162,790

Net cash provided by operating activities as a percent of revenue

43

%

37

%

Non-GAAP Financial Measures (*):

Non-GAAP income from operations

$

142,576

$

117,887

Non-GAAP operating margin

27

%

26

%

Non-GAAP net income

$

123,967

$

99,047

Non-GAAP net income per share - diluted

$

0.41

$

0.33

Non-GAAP shares outstanding - diluted

298,925

304,354

Free Cash Flow

$

212,403

$

145,528

Free Cash Flow margin

40

%

33

%

Full Year 2026 Financial Highlights

(Unaudited – In thousands, except per share data)

  Year Ended March 31,

2026

2025

Revenue:

Total revenue

$

2,018,387

$

1,698,683

Year-over-Year Increase

19

%

Year-over-Year Increase - constant currency (*)

17

%

Subscription revenue

$

1,929,722

$

1,622,163

Year-over-Year Increase

19

%

Year-over-Year Increase - constant currency (*)

17

%

GAAP Financial Measures:

GAAP income from operations

$

245,387

$

179,433

GAAP operating margin

12

%

11

%

GAAP net income (**)

$

162,669

$

483,684

GAAP net income per share - diluted (**)

$

0.54

$

1.59

GAAP shares outstanding - diluted

303,727

303,602

Net cash provided by operating activities

$

561,850

$

459,419

Net cash provided by operating activities as a percent of revenue

28

%

27

%

Non-GAAP Financial Measures (*):

Non-GAAP income from operations

$

591,929

$

493,540

Non-GAAP operating margin

29

%

29

%

Non-GAAP net income

$

517,641

$

422,313

Non-GAAP net income per share - diluted

$

1.70

$

1.39

Non-GAAP shares outstanding - diluted

303,727

303,602

Free Cash Flow

$

529,483

$

430,617

Free Cash Flow margin

26

%

25

%

  * For additional information, please see the "Non-GAAP Financial Measures" and "Definitions - Non-GAAP and Other Metrics" sections of this press release.

  ** During fiscal 2025, Dynatrace completed an intra-entity asset transfer of the global economic rights of intellectual property (IP) from a wholly-owned U.S. subsidiary to a wholly-owned Swiss subsidiary, more closely aligning IP rights with business operations. The transfer generated an income tax benefit of $320.9 million, or $1.06 per share on a dilutive basis.

Financial Outlook

Based on information available as of May 13, 2026, Dynatrace is issuing guidance for the first quarter and full year fiscal 2027 in the table below. Based on foreign exchange rates as of April 30, 2026, the foreign exchange tailwind relative to constant currency is expected to be approximately $10 million on ARR and $15 million on revenue for fiscal 2027. This guidance also excludes the impact of any share repurchases during fiscal 2027.

Growth rates for ARR, Total revenue, and Subscription revenue are presented in constant currency to provide better visibility into the underlying growth of the business.

All growth rates are compared to the first quarter and full year of fiscal 2026 ended March 31, 2026 unless otherwise noted.

  (In millions, except per share data)

First Quarter

Fiscal 2027

Full Year

Fiscal 2027

ARR

-

$2,382 - $2,402

As reported

-

16% - 17%

Constant currency

-

15.5% - 16.5%

Total revenue

$547 - $551

$2,317 - $2,335

As reported

15%

15% - 16%

Constant currency

13% - 14%

14% - 15%

Subscription revenue

$523 - $527

$2,217 - $2,235

As reported

14% - 15%

15% - 16%

Constant currency

13% - 14%

14% - 15%

Non-GAAP income from operations

$150 - $154

$682 - $690

Non-GAAP operating margin

27.5% - 28%

29.5%

Non-GAAP net income

$130 - $134

$584 - $594

Non-GAAP net income per diluted share

$0.44 - $0.45

$1.93 - $1.95

Diluted weighted average shares outstanding

298 - 299

302 - 304

Free cash flow

-

$613 - $620

Free cash flow margin

-

26.5%

Conference Call and Webcast Information

Dynatrace will host a conference call and live webcast to discuss its results and business outlook at 8:00 a.m. Eastern Time today, May 13, 2026. To access the conference call from the U.S. and Canada, dial (866) 405-1247, or internationally, dial (201) 689-8045 with event confirmation #: 13760309. The call will also be available live via webcast on the company’s website, ir.dynatrace.com.

An audio replay of the call will also be available until 11:59 p.m. Eastern Time on August 13, 2026 by dialing (877) 660-6853 from the U.S. or Canada, or for international callers by dialing (201) 612-7415 and entering event confirmation #: 13760309. In addition, an archived webcast will be available at ir.dynatrace.com.

We announce material financial information to our investors using our Investor Relations website, press releases, SEC filings and public conference calls and webcasts. We also use these channels to disclose information about the company, our planned financial and other announcements, attendance at upcoming investor and industry conferences, and for complying with our disclosure obligations under Regulation FD.

Non-GAAP Financial Measures

In addition to disclosing financial measures prepared in accordance with GAAP, this press release and the accompanying tables contain certain non-GAAP financial measures as defined by Regulation G, including non-GAAP income from operations, non-GAAP operating margin, non-GAAP net income, non-GAAP net income per diluted share, free cash flow, and free cash flow margin. We also use or discuss non-GAAP financial measures in conference calls, slide presentations and webcasts.

We use these non-GAAP financial measures for financial and operational decision-making purposes, and as a means to evaluate period-to-period comparisons and liquidity. We believe that these non-GAAP financial measures provide useful information about our operating results, enhance the overall understanding of past financial performance and allow for greater transparency with respect to metrics used by our management in its financial and operational decision-making.

The presentation of the non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. Our non-GAAP financial measures may not provide information that is directly comparable to similarly titled metrics provided by other companies.

Non-GAAP financial measures are defined in this press release and the tables included in this press release include reconciliations of historical non-GAAP financial measures to their most directly comparable GAAP measures.

We also include non-GAAP financial measures in our financial outlook included in this press release. Reconciliations of forward-looking non-GAAP income from operations, non-GAAP net income, non-GAAP net income per diluted share, and free cash flow guidance to the most directly comparable GAAP measures are not available without unreasonable efforts due to the high variability, complexity, and low visibility with respect to the charges excluded from these non-GAAP measures; in particular, the measures and effects of share-based compensation expense, employer taxes and tax deductions specific to equity compensation awards that are directly impacted by future hiring, turnover and retention needs, as well as unpredictable fluctuations in our stock price. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.

Definitions - Non-GAAP and Other Metrics

Annual Recurring Revenue (ARR) is defined as the daily revenue of all subscription agreements that are actively generating revenue as of the last day of the reporting period multiplied by 365. We exclude from our calculation of ARR any revenues derived from month-to-month agreements and/or product usage overage billings.

Constant Currency amounts for ARR, Total revenue, and Subscription revenue are presented to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign exchange rate fluctuations. To present this information, current and comparative prior period results for entities reporting in currencies other than United States dollars are converted into United States dollars using the average exchange rates from the comparative period rather than the actual exchange rates in effect during the respective periods. All growth comparisons relate to the corresponding period in the last fiscal year.

Non-GAAP Income from Operations is defined as GAAP income from operations adjusted for the following items: share-based compensation; employer payroll taxes on employee stock transactions; amortization of intangibles; transaction, restructuring and other non-recurring or unusual items that may arise from time to time. The related Non-GAAP Operating Margin is non-GAAP income from operations expressed as a percentage of total revenue.

Non-GAAP Net Income is defined as GAAP net income adjusted for the following items: income tax expense/benefit; non-GAAP effective cash taxes; net interest expense and income; net cash received from and paid for interest; share-based compensation; employer payroll taxes on employee stock transactions, amortization of intangibles; gains and losses on currency translation; and transaction, restructuring and other non-recurring or unusual items that may arise from time to time. Non-GAAP net income per diluted share is calculated as non-GAAP net income divided by the diluted weighted average shares outstanding used to compute GAAP net income per diluted share.

Free Cash Flow is defined as the net cash provided by or used in operating activities less capital expenditures, reflected as purchase of property and equipment and capitalized software additions in our financial statements. The related margin is free cash flow expressed as a percentage of total revenue.

About Dynatrace

Dynatrace (NYSE: DT) is advancing observability for today’s digital businesses, helping to transform the complexity of modern digital ecosystems into powerful business assets. By leveraging AI-powered insights, Dynatrace enables organizations to analyze, automate, and innovate faster to drive their business forward. To learn more about Dynatrace, visit www.dynatrace.com, visit our blog and follow us on LinkedIn and X @dynatrace.

Dynatrace and the Dynatrace logo are trademarks of the Dynatrace, Inc. group of companies. All other trademarks are the property of their respective owners. © 2026 Dynatrace LLC.

Cautionary Language Concerning Forward-Looking Statements

This press release includes certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's objective to accelerate ARR growth while delivering balanced growth and profitability, the company's plans to invest in innovation and growth while delivering value to shareholders, the expected and current benefits that we believe organizations receive from using the Dynatrace platform and offerings of our partners and other companies with which we collaborate and integrate, and our financial and business outlook, including our financial guidance for the first quarter and full year of fiscal 2027. These forward-looking statements include, but are not limited to, plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts and statements identified by words such as “will,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” or words of similar meaning. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control including, without limitation, our ability to maintain our revenue growth rates in future periods; market adoption of our product offerings; continued demand for, and spending on, our solutions; our ability to innovate and develop solutions that meet customer needs as cloud and AI workloads grow rapidly; the ability of our platform and solutions to effectively interoperate with customers’ IT infrastructures; our ability to acquire new customers and retain and expand our relationships with existing customers; our ability to expand our sales and marketing capabilities; our ability to compete; our ability to maintain successful relationships with partners; security breaches, other security incidents and any real or perceived errors, failures, defects or vulnerabilities in our solutions; our ability to protect our intellectual property; our ability to hire and retain necessary qualified employees to grow our business and expand our operations; our ability to successfully complete acquisitions and to integrate newly acquired businesses and offerings; the effect on our business of the macroeconomic environment, associated global economic conditions and geopolitical disruption; and other risks set forth under the caption “Risk Factors” in our Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q, and our other SEC filings. We assume no obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

DYNATRACE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited - In thousands, except per share data)

  Three Months Ended March 31,

Twelve Months Ended March 31,

2026

2025

2026

2025

Revenue:

Subscription

$

505,754

$

423,570

$

1,929,722

$

1,622,163

Service

25,962

21,595

88,665

76,520

Total revenue

531,716

445,165

2,018,387

1,698,683

Cost of revenue:

Cost of subscription

77,356

63,265

284,611

233,299

Cost of service

23,112

21,095

84,105

73,631

Amortization of acquired technology

927

734

3,488

13,262

Total cost of revenue

101,395

85,094

372,204

320,192

Gross profit

430,321

360,071

1,646,183

1,378,491

Operating expenses:

Research and development

130,579

103,285

474,312

384,572

Sales and marketing

183,442

161,797

690,489

605,599

General and administrative

60,413

52,062

217,414

195,347

Amortization of other intangibles

20

13

56

13,540

Impairment of long-lived assets

18,525

—

18,525

—

Total operating expenses

392,979

317,157

1,400,796

1,199,058

Income from operations

37,342

42,914

245,387

179,433

Interest income, net

10,111

10,930

47,731

48,281

Other (expense) income, net

(638

)

1,860

6,643

(4,285

)

Income before income taxes

46,815

55,704

299,761

223,429

Income tax (expense) benefit

(29,399

)

(16,400

)

(137,092

)

260,255

Net income

$

17,416

$

39,304

$

162,669

$

483,684

Net income per share:

Basic

$

0.06

$

0.13

$

0.54

$

1.62

Diluted

$

0.06

$

0.13

$

0.54

$

1.59

Weighted average shares outstanding:

Basic

297,544

299,441

300,102

298,384

Diluted

298,925

304,354

303,727

303,602

SHARE-BASED COMPENSATION

  Three Months Ended March 31,

Twelve Months Ended March 31,

2026

2025

2026

2025

Cost of revenue

$

9,619

$

9,659

$

40,276

$

36,924

Research and development

28,371

26,097

114,110

100,866

Sales and marketing

19,987

19,855

84,480

77,336

General and administrative

15,022

14,593

60,760

56,577

Total share-based compensation expense

$

72,999

$

70,204

$

299,626

$

271,703

DYNATRACE, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited - In thousands, except share data)

  March 31,

2026

2025

Assets

Current assets:

Cash and cash equivalents

$

1,097,220

$

1,017,039

Short-term marketable securities

74,881

96,189

Accounts receivable, net

710,200

624,437

Deferred contract costs, current

127,495

109,895

Prepaid expenses and other current assets

113,651

83,901

Total current assets

2,123,447

1,931,461

Long-term marketable securities

51,908

51,648

Property and equipment, net

72,993

61,522

Operating lease right-of-use asset, net

139,285

67,479

Goodwill

1,350,256

1,336,435

Intangible assets, net

22,850

25,534

Deferred tax assets, net

508,742

529,550

Deferred contract costs, non-current

113,111

95,297

Other assets

33,133

40,752

Total assets

$

4,415,725

$

4,139,678

Liabilities and shareholders' equity

Current liabilities:

Accounts payable

$

2,728

$

27,286

Accrued expenses, current

302,260

252,503

Deferred revenue, current

1,241,488

1,087,518

Operating lease liabilities, current

22,588

13,979

Total current liabilities

1,569,064

1,381,286

Deferred revenue, non-current

53,387

50,989

Accrued expenses, non-current

38,205

24,452

Operating lease liabilities, non-current

141,736

61,384

Deferred tax liabilities

1,943

419

Total liabilities

1,804,335

1,518,530

Shareholders' equity:

Common shares, $0.001 par value, 600,000,000 shares authorized, 294,652,951 and 299,813,048 shares issued and outstanding at March 31, 2026 and 2025, respectively

295

300

Additional paid-in capital

2,199,494

2,370,563

Retained earnings

447,596

284,927

Accumulated other comprehensive loss

(35,995

)

(34,642

)

Total shareholders' equity

2,611,390

2,621,148

Total liabilities and shareholders' equity

$

4,415,725

$

4,139,678

DYNATRACE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited - In thousands)

  Three Months Ended March 31,

Twelve Months Ended March 31,

2026

2025

2026

2025

Cash flows from operating activities:

Net income

$

17,416

$

39,304

$

162,669

$

483,684

Adjustments to reconcile net income to cash provided by operations:

Depreciation

4,702

5,385

18,446

19,236

Amortization

1,462

1,265

5,613

28,868

Share-based compensation

72,999

70,204

299,626

271,703

Deferred income taxes

6,658

(14,147

)

25,132

(392,942

)

Impairment of long-lived assets

18,525

—

18,525

—

Other

989

(2,100

)

(6,928

)

2,035

Net change in operating assets and liabilities:

Accounts receivable

(245,159

)

(228,277

)

(77,127

)

(24,026

)

Deferred contract costs

(7,203

)

(11,613

)

(31,057

)

(14,648

)

Prepaid expenses and other assets

(24,981

)

(15,020

)

(15,977

)

(36,593

)

Accounts payable and accrued expenses

56,344

59,142

25,896

31,534

Operating leases, net

978

(665

)

2,434

(231

)

Deferred revenue

323,631

259,312

134,598

90,799

Net cash provided by operating activities

226,361

162,790

561,850

459,419

Cash flows from investing activities:

Purchase of property and equipment

(13,958

)

(14,566

)

(32,173

)

(26,106

)

Capitalized software additions

—

(2,696

)

(194

)

(2,696

)

Acquisition of businesses, net of cash acquired

(6,000

)

—

(6,000

)

(100

)

Purchases of marketable securities

(11,448

)

(37,566

)

(120,306

)

(145,555

)

Proceeds from sales and maturities of marketable securities

39,847

36,997

143,729

105,142

Other

(750

)

—

(750

)

—

Net cash provided by (used in) investing activity

7,691

(17,831

)

(15,694

)

(69,315

)

Cash flows from financing activities:

Proceeds from employee stock purchase plan

—

—

24,390

21,159

Proceeds from exercise of stock options

1,786

6,092

6,487

20,995

Repurchases of common stock

(223,675

)

(42,518

)

(478,708

)

(172,618

)

Taxes paid related to net share settlement of equity awards

(2,211

)

(2,620

)

(21,845

)

(18,958

)

Other

(552

)

(552

)

(4,418

)

(2,208

)

Net cash used in financing activities

(224,652

)

(39,598

)

(474,094

)

(151,630

)

Effect of exchange rates on cash and cash equivalents

(3,714

)

4,196

8,119

(418

)

Net increase in cash and cash equivalents

5,686

109,557

80,181

238,056

Cash and cash equivalents, beginning of period

1,091,534

907,482

1,017,039

778,983

Cash and cash equivalents, end of period

$

1,097,220

$

1,017,039

$

1,097,220

$

1,017,039

DYNATRACE, INC.

GAAP to Non-GAAP Reconciliations

(Unaudited - In thousands, except percentages)

  Three Months Ended March 31,

Twelve Months Ended March 31,

2026

2025

2026

2025

Non-GAAP cost of revenue:

Cost of revenue

$

101,395

$

85,094

$

372,204

$

320,192

Share-based compensation

(9,619

)

(9,659

)

(40,276

)

(36,924

)

Employer payroll taxes on employee stock transactions

(489

)

(661

)

(2,458

)

(2,447

)

Amortization of intangibles

(927

)

(734

)

(3,488

)

(13,262

)

Transaction, restructuring, and other

(1,475

)

—

(1,475

)

—

Non-GAAP cost of revenue

$

88,885

$

74,040

$

324,507

$

267,559

Non-GAAP gross profit:

Gross profit

$

430,321

$

360,071

$

1,646,183

$

1,378,491

Share-based compensation

9,619

9,659

40,276

36,924

Employer payroll taxes on employee stock transactions

489

661

2,458

2,447

Amortization of intangibles

927

734

3,488

13,262

Transaction, restructuring, and other

1,475

—

1,475

—

Non-GAAP gross profit

$

442,831

$

371,125

$

1,693,880

$

1,431,124

GAAP gross margin

81

%

81

%

82

%

81

%

Non-GAAP gross margin

83

%

83

%

84

%

84

%

Non-GAAP operating expenses:

Operating expenses

$

392,979

$

317,157

$

1,400,796

$

1,199,058

Share-based compensation

(63,380

)

(60,545

)

(259,350

)

(234,779

)

Employer payroll taxes on employee stock transactions

(2,719

)

(3,309

)

(12,834

)

(12,997

)

Amortization of intangibles

(20

)

(13

)

(56

)

(13,540

)

Transaction, restructuring, and other

(26,605

)

(52

)

(26,605

)

(158

)

Non-GAAP operating expenses

$

300,255

$

253,238

$

1,101,951

$

937,584

Non-GAAP income from operations:

Income from operations

$

37,342

$

42,914

$

245,387

$

179,433

Share-based compensation

72,999

70,204

299,626

271,703

Employer payroll taxes on employee stock transactions

3,208

3,970

15,292

15,444

Amortization of intangibles

947

747

3,544

26,802

Transaction, restructuring, and other

28,080

52

28,080

158

Non-GAAP income from operations

$

142,576

$

117,887

$

591,929

$

493,540

GAAP operating margin

7

%

10

%

12

%

11

%

Non-GAAP operating margin

27

%

26

%

29

%

29

%

DYNATRACE, INC.

GAAP to Non-GAAP Reconciliations

(Unaudited - In thousands, except per share data)

  Three Months Ended March 31,

Twelve Months Ended March 31,

2026

2025

2026

2025

Non-GAAP net income:

Net income

$

17,416

$

39,304

162,669

483,684

Income tax expense (benefit)

29,399

16,400

137,092

(260,255

)

Non-GAAP effective cash tax

(28,223

)

(29,616

)

(117,584

)

(118,154

)

Interest income, net

(10,111

)

(10,930

)

(47,731

)

(48,281

)

Cash received from interest, net

9,614

10,776

43,296

46,927

Share-based compensation

72,999

70,204

299,626

271,703

Employer payroll taxes on employee stock transactions

3,208

3,970

15,292

15,444

Amortization of intangibles

947

747

3,544

26,802

Transaction, restructuring, and other

28,080

52

28,080

158

Loss (gain) on currency translation

638

(1,860

)

(6,643

)

4,285

Non-GAAP net income

$

123,967

$

99,047

$

517,641

$

422,313

Share count:

Weighted-average shares outstanding - basic

297,544

299,441

300,102

298,384

Weighted-average shares outstanding - diluted

298,925

304,354

303,727

303,602

Shares used in non-GAAP per share calculations:

Weighted-average shares outstanding - basic

297,544

299,441

300,102

298,384

Weighted-average shares outstanding - diluted

298,925

304,354

303,727

303,602

Non-GAAP net income per share:

Net income per share - basic

$

0.06

$

0.13

$

0.54

$

1.62

Net income per share - diluted

$

0.06

$

0.13

$

0.54

$

1.59

Non-GAAP net income per share - basic

$

0.42

$

0.33

$

1.72

$

1.42

Non-GAAP net income per share - diluted

$

0.41

$

0.33

$

1.70

$

1.39

Three Months Ended March 31,

Twelve Months Ended March 31,

2026

2025

2026

2025

Free cash flow:

Net cash provided by operating activities

$

226,361

$

162,790

$

561,850

$

459,419

Purchase of property and equipment

(13,958

)

(14,566

)

(32,173

)

(26,106

)

Capitalized software additions

—

(2,696

)

(194

)

(2,696

)

Free cash flow

$

212,403

$

145,528

$

529,483

$

430,617

Dynatrace (DT - Free Report) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +7.94%. A quarter ago, it was expected that this software intellegence company would post earnings of $0.41 per share when it actually produced earnings of $0.44, delivering a surprise of +7.32%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Dynatrace, which belongs to the Zacks Computers - IT Services industry, posted revenues of $531.72 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 2.13%. This compares to year-ago revenues of $445.17 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Dynatrace shares have lost about 9.5% since the beginning of the year versus the S&P 500's gain of 8.1%.

What's Next for Dynatrace?While Dynatrace has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Dynatrace was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.45 on $546.7 million in revenues for the coming quarter and $1.91 on $2.3 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the bottom 43% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Nutanix (NTNX - Free Report) , another stock in the same industry, has yet to report results for the quarter ended April 2026. The results are expected to be released on May 27.

This enterprise cloud platform services provider is expected to post quarterly earnings of $0.35 per share in its upcoming report, which represents a year-over-year change of -16.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Nutanix's revenues are expected to be $686 million, up 7.4% from the year-ago quarter.

Dynatrace DT is experiencing a significant decline in its stock price following the release of its Q4 earnings report and guidance for FY27. Although the company reported results that exceeded expectations, the market reaction has been negative. Key highlights include:

Q4 Performance: Adjusted EPS rose to $0.41, beating estimates by $0.02, while revenue increased by 19.4% year-over-year to $531.7 million. FY27 Guidance: The company provided EPS and revenue forecasts above consensus, anticipating an ARR growth of 15.5-16.5%. Enterprise Momentum: Dynatrace achieved a record 22 deals exceeding $1 million in annual contract value (ACV), including nine new-logo seven-figure contracts. Management noted a rising demand for observability vendor consolidation as AI workloads complicate infrastructure. ARR Stability: ARR growth remained steady at 16% for the fourth consecutive quarter, with over 75% of ARR now coming from DPS adoption. Gross retention rates stayed in the mid-90% range, while net revenue retention (NRR) held at 110%. AI Adoption: The trend of AI adoption is strengthening, with over 850 customers using Dynatrace for monitoring AI and large language model (LLM) workloads, and more than 500 utilizing agentic AI capabilities. Log management consumption surged over 100% year-over-year, exceeding $100 million in annualized consumption. Profitability: The company reported a FY26 operating margin of 29% and generated free cash flow of $529 million, representing 26% of revenue. Additionally, Dynatrace repurchased $479 million of its stock during FY26. Market Reaction: Despite the strong FY27 guidance, investors may have anticipated a more pronounced ARR acceleration, especially in light of management's optimistic commentary on AI. DT also foresees a temporary gross margin headwind due to increased cloud hosting costs associated with higher platform consumption.In summary, Dynatrace DT has showcased operational strength, highlighted by impressive earnings, substantial enterprise deal activity, and a surge in AI adoption. However, the stock's decline reflects investor concerns regarding the pace of ARR growth and net expansion trends. Nevertheless, DT continues to position itself as a crucial player in the observability and AI operations market, with innovations like Grail and Davis AI potentially driving long-term growth.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

3 Stocks Flashing Rare Buy Signals After the Market's Wildest MonthDynatrace NYSE: DT reported a stronger finish to fiscal 2026, with executives emphasizing steady annual recurring revenue growth, expanding consumption of its log management products and growing demand tied to artificial intelligence and cloud complexity.

On the company’s fourth-quarter and full-year earnings call, Chief Executive Officer Rick McConnell said Dynatrace surpassed $2 billion in annual recurring revenue, or ARR, and delivered its fourth consecutive quarter of 16% ARR growth. He said the company also saw log management annualized consumption rise to “well over $100 million,” growing more than 100% annually.

Get Dynatrace alerts:

DTE’s Stargate Deal Turns Power Into Profits“Dynatrace delivered a strong finish to fiscal 2026, marked by meaningful scale, durable execution, and continued innovation,” McConnell said.

ARR Tops $2 Billion as New Logo Activity Improves Chief Financial Officer Jim Benson said ARR ended the year at $2.05 billion, up 16% year over year in constant currency. He said fourth-quarter net new ARR, adjusted for foreign exchange movements, was $81 million, near the high end of the company’s guidance. For the full fiscal year, net new ARR was $277 million, representing 12% growth.

Amid the "SaaS Apocalypse," These 3 Names Are Boosting BuybacksBenson said Dynatrace added 126 new logos in the fourth quarter, including a record nine seven-figure new customer lands. The average land size in the quarter remained above $200,000, and new logo ARR rose 43% in the quarter and 30% in the second half of the year.

The company also highlighted larger strategic deals. McConnell said Dynatrace recorded 22 deals with incremental annual contract value of more than $1 million in the fourth quarter. He attributed the large-deal momentum to enterprise customers seeking to consolidate fragmented monitoring and observability tools.

“There is significant interest in integrating fragmented tools to save money,” McConnell said during the question-and-answer portion of the call. He added that Dynatrace’s go-to-market changes have helped the company build deeper relationships with C-level decision-makers.

Revenue, Margins and Cash Flow Fourth-quarter total revenue was $532 million, while subscription revenue was $506 million. Both increased 16% and exceeded the high end of Dynatrace’s guidance range by 200 basis points, Benson said.

For the full fiscal year, total revenue was $2.02 billion and subscription revenue was $1.93 billion, both up 17%. Non-GAAP operating margin was 29% for the year, and non-GAAP net income was $518 million, or $1.70 per diluted share.

Free cash flow totaled $529 million, or 26% of revenue. Benson said pre-tax free cash flow was 32% of revenue, noting that Dynatrace pays more cash taxes than many software peers because of its GAAP profitability.

The company also increased share repurchases. Benson said Dynatrace bought back 5.9 million shares for $224 million in the fourth quarter and 11.4 million shares for $479 million during the fiscal year. As of March 31, Dynatrace had about $849 million remaining under its $1 billion share repurchase authorization.

AI and Platform Consumption Remain Central Themes McConnell said observability is becoming more important as enterprises adopt AI systems and agentic architectures that require continuous validation, governance, auditability, cost control and security oversight. He said Dynatrace’s platform is designed to provide “answers, not guesses” through deterministic and causal insights.

McConnell described Dynatrace’s advantage as architectural rather than feature-based, pointing to three core platform components: Grail, an AI data lakehouse; Smartscape, a real-time topology graph; and Dynatrace Intelligence, which provides both insights and automated action.

He said more than 500 customers are deploying Dynatrace’s agentic capabilities to support autonomous operations and integrations with AI development tools such as Anthropic’s Claude Code and GitHub Copilot. He also said more than 850 customers are using Dynatrace to observe AI and large language model workloads in production.

The company also discussed recent acquisitions. McConnell said Dynatrace acquired DevCycle, a feature management company, and Bindplane, an open standards-based telemetry pipeline company, as it entered the new fiscal year. He said Bindplane should support expanded ingest from OpenTelemetry and simplify telemetry collection and routing at scale.

DPS Licensing Model Drives Broader Usage Benson said the Dynatrace Platform Subscription, or DPS, licensing model now represents more than 75% of ARR and more than 60% of the customer base. He said DPS customers are adopting the platform more broadly and consuming more than non-DPS customers.

Gross retention in the fourth quarter remained in the mid-90% range, while trailing 12-month net retention was 110%. Benson said average ARR per customer is now above $500,000 and said the company believes the long-term opportunity could be $1 million or more per customer.

In response to analyst questions, Benson said fiscal 2027 will include the largest cohort of DPS customers coming up for annual resets or renewals, creating an opportunity for expansion depending on consumption growth.

Fiscal 2027 Guidance Calls for ARR Acceleration Dynatrace guided for fiscal 2027 ARR of $2.38 billion to $2.4 billion, representing growth of 15.5% to 16.5%. The guidance implies net new ARR, adjusted for foreign exchange movements, of $320 million to $340 million, up 16% to 23% from fiscal 2026 levels.

Benson said net new ARR is expected to be modestly more weighted toward the first half of the year than historical seasonality, citing healthy forecasted pipeline coverage.

For fiscal 2027, Dynatrace expects total revenue of $2.32 billion to $2.34 billion and subscription revenue of $2.22 billion to $2.24 billion, both representing growth of 14% to 15%. The company guided for non-GAAP operating margin of about 29.5%, non-GAAP net income of $584 million to $594 million and non-GAAP earnings of $1.93 to $1.95 per diluted share.

Benson said operating expense leverage is expected to be partially offset by a 100-basis-point gross margin headwind from higher cloud hosting costs tied to platform consumption growth. He said the pressure is expected to be temporary, with gross margins beginning to recover in fiscal 2028.

For the first quarter, Dynatrace expects total revenue of $547 million to $551 million, subscription revenue of $523 million to $527 million and non-GAAP earnings of $0.44 to $0.45 per diluted share.

About Dynatrace NYSE: DTDynatrace is a global software intelligence company specializing in application performance management (APM), cloud infrastructure monitoring, and digital experience management. Its flagship offering, the Dynatrace Software Intelligence Platform, leverages artificial intelligence to provide real-time observability across distributed environments, including on-premises data centers, private clouds, public clouds and hybrid deployments. Organizations rely on Dynatrace to detect anomalies, troubleshoot performance issues and optimize end-user experiences through automated root-cause analysis powered by the company's engine, Davis.

The Dynatrace platform comprises modules for full-stack application monitoring, digital experience monitoring, infrastructure monitoring and business analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Dynatrace Right Now?Before you consider Dynatrace, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dynatrace wasn't on the list.

While Dynatrace currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Dynatrace, Inc (NYSE:DT) on Wednesday reported upbeat fourth-quarter financial results and issued first-quarter sales guidance below estimates.

Dynatrace reported quarterly earnings of 41 cents per share which beat the analyst consensus estimate of 39 cents per share. The company reported quarterly sales of $531.716 million which beat the analyst consensus estimate of $520.670 million.

Dynatrace said it sees first-quarter adjusted EPS of 44 cents to 45 cents, versus market estimates of 45 cents. The company sees sales of $547.000 million to $551.000 million, versus estimates of $552.627 million.

Dynatrace shares gained 4.1% to trade at $36.13 on Thursday.

These analysts made changes to their price targets on Dynatrace following earnings announcement.

BMO Capital analyst Keith Bachman maintained the stock with an Outperform rating and lowered the price target from $45 to $43. Barclays analyst Raimo Lenschow maintained the stock with an Overweight rating and cut the price target from $47 to $44. Considering buying DT stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Dynatrace delivered Q4 revenue of $531.7M (+19.4% y/y), beating estimates, with 95% recurring subscription revenue and robust free cash flow generation. Despite strong financial health, including $1.1B in cash and no debt, DT faces market concerns over ARR growth deceleration to 16%-17% and cautious FY guidance. DT's AI observability products and integration with major hyperscalers position it well to adapt, countering fears of obsolescence from AI disruption.

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.

In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.

However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.

Our proprietary system currently recommends Dynatrace (DT - Free Report) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank.

Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.

While there are numerous reasons why the stock of this software intellegence company is a great growth pick right now, we have highlighted three of the most important factors below:

Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.

While the historical EPS growth rate for Dynatrace is 20.5%, investors should actually focus on the projected growth. The company's EPS is expected to grow 13.3% this year, crushing the industry average, which calls for EPS growth of 8.7%.

Cash Flow GrowthCash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.

Right now, year-over-year cash flow growth for Dynatrace is 8.8%, which is higher than many of its peers. In fact, the rate compares to the industry average of 8.4%.

While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 10.7% over the past 3-5 years versus the industry average of 8.5%.

Promising Earnings Estimate RevisionsSuperiority of a stock in terms of the metrics outlined above can be further validated by looking at the trend in earnings estimate revisions. A positive trend is of course favorable here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

There have been upward revisions in current-year earnings estimates for Dynatrace. The Zacks Consensus Estimate for the current year has surged 0.9% over the past month.

Bottom LineDynatrace has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

This combination indicates that Dynatrace is a potential outperformer and a solid choice for growth investors.

© Shutterstock / Piotr Swat

Shares of Palantir (NASDAQ:PLTR | PLTR Price Prediction) are up 10% in Friday morning trading, changing hands near $158. The pop follows a blockbuster quarter from Dell Technologies (NYSE:DELL), reported Thursday evening, that validated a high-profile partnership the two companies unveiled earlier this month.

Even with today’s rally, Palantir stock is still down 12% year to date (YTD), so this looks more like a recovery leg than a clean breakout. The catalyst is unusual because it lives inside someone else’s earnings report rather than Palantir’s own results.

A second tailwind comes from Snowflake (NYSE:SNOW). The data cloud specialist’s Wednesday earnings report kicked off a broader software and AI platform rally that carried into Friday’s open.

Dell’s AI Server Surge Validates the Partnership Dell reported Q1 FY2027 revenue of $43.84 billion, beating estimates by 23% and growing 88% year over year (YoY). Non-GAAP EPS came in at $4.86 versus a $2.96 consensus, a 64% beat. AI-optimized server revenue jumped 757% YoY to $16.13 billion.

The company also booked $24.4 billion in AI orders during the quarter and raised full-year FY27 AI server revenue guidance to approximately $60 billion. DELL stock is up 29% today, trading near $409.

That matters for Palantir because the two companies unveiled a deep tie-up at Dell Technologies World on May 18. Palantir’s Foundry and AIP platforms are coming on-premises to the Dell AI Factory with NVIDIA (NASDAQ:NVDA), with the Ontology layer running on Dell ObjectScale and PowerFlex storage. Palantir Rubix and Apollo handle the zero-trust runtime layer, targeting sovereign, defense, and regulated workloads.

Snowflake Sparks a Broader Software Rally Snowflake reported Q1 FY27 revenue of $1.39 billion, up 34% YoY, with non-GAAP EPS of $0.39 beating by 22%. The company raised its full-year product revenue guidance to $5.84 billion, a 31% growth pace, and disclosed more than 13,600 accounts using its AI capabilities.

CEO Sridhar Ramaswamy declared that Q1 marks “a clear inflection point” in Snowflake’s AI journey, positioning the platform as “the control plane for the Agentic Enterprise.” Dynatrace (NYSE:DT) and other observability and AI platform names are riding the same wave, with DT shares up 4% Friday.

Gartner Forecast Adds a Macro Tailwind Underneath the day’s headlines sits a constructive top-down call. Gartner expects AI software spending to grow 60% to $453 billion in 2026, a forecast that frames Palantir’s AIP platform as a beneficiary of one of the largest enterprise software spending waves in years.

NVIDIA’s earlier Q1 earnings report reinforced that backdrop. CEO Jensen Huang asserted that the “buildout of AI factories, the largest infrastructure expansion in human history, is accelerating.” Palantir sits at the software layer of that exact stack, riding above Dell hardware and NVIDIA silicon.

What to Watch Palantir stock trades at a P/E ratio of 203x, so the bull case still relies on durable AI software demand and continued execution on the Dell partnership. However, the bear case argues today’s move is sympathy buying that fades once the Dell euphoria cools.

Polymarket contracts assign a 98% probability that PLTR finishes Friday in the green, with crowd targets clustered around $150 to $156 into next week. Reddit sentiment on r/WallStreetBets recovered to a 75 bullish score by Thursday evening, after collapsing earlier in the week on a viral bearish post.

Cautious investors may want to watch for whether the gains hold into the close and whether Monday’s regular session brings follow-through buying or profit-taking. The next major Palantir-specific catalyst is the company’s own earnings report, but until then the stock will likely trade as a derivative of the broader AI infrastructure tape.

Posted by Defense World Staff on Apr 6th, 2026

JPMorgan Chase & Co. lessened its position in Coursera, Inc. (NYSE:COUR – Free Report) by 73.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 218,303 shares of the company’s stock after selling 591,643 shares during the period. JPMorgan Chase & Co. owned about 0.13% of Coursera worth $2,556,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Vanguard Group Inc. raised its holdings in Coursera by 2.6% in the 3rd quarter. Vanguard Group Inc. now owns 13,921,600 shares of the company’s stock valued at $163,022,000 after acquiring an additional 357,264 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Coursera by 341.6% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,955,723 shares of the company’s stock worth $34,612,000 after purchasing an additional 2,286,395 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Coursera by 5.9% during the third quarter. Dimensional Fund Advisors LP now owns 2,704,855 shares of the company’s stock worth $31,679,000 after purchasing an additional 151,000 shares during the last quarter. Lazard Asset Management LLC grew its position in shares of Coursera by 84.2% in the third quarter. Lazard Asset Management LLC now owns 2,319,515 shares of the company’s stock valued at $27,162,000 after purchasing an additional 1,060,288 shares during the period. Finally, Qube Research & Technologies Ltd grew its position in shares of Coursera by 6.6% in the second quarter. Qube Research & Technologies Ltd now owns 1,883,396 shares of the company’s stock valued at $16,499,000 after purchasing an additional 115,898 shares during the period. Hedge funds and other institutional investors own 89.55% of the company’s stock.

Wall Street Analysts Forecast Growth Several research firms recently weighed in on COUR. The Goldman Sachs Group reduced their target price on Coursera from $9.00 to $6.00 and set a “sell” rating on the stock in a research report on Saturday, February 7th. Royal Bank Of Canada dropped their price objective on shares of Coursera from $11.00 to $8.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Telsey Advisory Group reiterated an “outperform” rating and set a $14.00 price objective on shares of Coursera in a report on Friday, February 6th. Needham & Company LLC reissued a “buy” rating and issued a $10.00 target price on shares of Coursera in a research report on Friday, February 6th. Finally, BMO Capital Markets restated an “outperform” rating and issued a $8.00 target price on shares of Coursera in a report on Friday, February 6th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $10.62.

View Our Latest Stock Report on Coursera

Insider Buying and Selling In other Coursera news, SVP Alan B. Cardenas sold 9,710 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $5.92, for a total transaction of $57,483.20. Following the transaction, the senior vice president owned 217,876 shares in the company, valued at $1,289,825.92. The trade was a 4.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 16.80% of the stock is owned by company insiders.

Coursera Stock Down 0.2% COUR opened at $5.90 on Monday. Coursera, Inc. has a 52-week low of $5.47 and a 52-week high of $13.56. The company has a 50 day moving average of $6.04 and a two-hundred day moving average of $7.73. The company has a market cap of $998.76 million, a P/E ratio of -19.03 and a beta of 1.35.

Coursera (NYSE:COUR – Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $0.06 EPS for the quarter, meeting analysts’ consensus estimates of $0.06. Coursera had a negative net margin of 6.73% and a negative return on equity of 5.17%. The business had revenue of $196.90 million for the quarter, compared to the consensus estimate of $191.83 million. During the same quarter last year, the firm posted $0.08 EPS. The business’s revenue for the quarter was up 9.9% compared to the same quarter last year. Research analysts anticipate that Coursera, Inc. will post -0.28 earnings per share for the current year.

Coursera Company Profile (Free Report)

Coursera, Inc (NYSE:COUR) operates a leading online learning platform that delivers courses, specializations, professional certificates and fully accredited degree programs in collaboration with top universities and industry partners. Founded in 2012 by Stanford University professors Andrew Ng and Daphne Koller, Coursera’s mission is to provide universal access to world-class education and bridge skill gaps in a rapidly evolving job market.

The platform features more than 6,000 offerings created by over 275 academic institutions and corporate entities, spanning fields such as data science, business, technology, health care and the arts.

Featured Stories Five stocks we like better than Coursera Want to see what other hedge funds are holding COUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Coursera, Inc. (NYSE:COUR – Free Report).

Receive News & Ratings for Coursera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coursera and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINESG Americas Securities LLC Trims Position in Magnolia Oil & Gas Corp $MGY

NEXT HEADLINE »SG Americas Securities LLC Grows Position in WisdomTree, Inc. $WT

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera, Inc. (NYSE: COUR), a leading global online learning platform, today announced it will release its financial results for the first quarter ended March 31, 2026 after the U.S. stock market closes on Thursday, April 23, 2026. The company will issue the results via a press release with accompanying consolidated financial information before holding a conference call broadcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time).

Conference Call Details

A live, audio-only webcast of the conference call and earnings release materials will be available to the public on the company’s investor relations website at investor.coursera.com. An archived replay will be accessible in the same location for one year.

Disclosure Information

In compliance with disclosure obligations under Regulation FD, Coursera announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via Coursera’s investor relations website.

About Coursera

Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Today, it is one of the largest online learning platforms in the world, with 197 million registered learners as of December 31, 2025. Coursera partners with over 375 leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including generative AI-powered features like Coach, Role Play, and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp.

Source Code: COUR-IR

Here’s a look inside the report.

COUR stock is moving. Watch the price action here. Coursera Q1 DetailsCoursera reported quarterly earnings of seven cents per share, which missed the analyst consensus estimate of eight cents and was down from earnings of 12 cents from the same period last year.

Quarterly revenue came in at $195.7 million, which beat the analyst consensus estimate of $195.05 million, according to Benzinga Pro data. 

Coursera reported the following first-quarter highlights:

Grew Consumer segment revenue by 10% year-over-year, the fourth consecutive quarter of double-digit growth Added a first-quarter record of 7.6 million new registered learners, bringing the cumulative total registered learners to 205 million “Coursera delivered a strong start to 2026, including our fourth consecutive quarter of double-digit year-over-year consumer revenue growth and a first quarter record of 7.6 million new registered learners,” said Coursera CEO Greg Hart.

Outlook: Coursera reaffirmed its fiscal 2026 revenue guidance of $805 million to $815.000 million, versus the $812.68 million analyst estimate.

COUR Stock Price: According to data from Benzinga Pro, Coursera stock was down 10.22% to $5.36 in Thursday's extended trading.  

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Coursera, Inc. (COUR) Q1 2026 Earnings Call Transcript

Coursera faces deteriorating fundamentals and heightened operating risks, prompting a downgrade to neutral despite recent share price declines. Q1 results revealed enterprise segment weakness and shrinking adjusted EBITDA margins due to increased product and sales investments. Consumer segment growth remains robust, driven by expanding AI content and a growing registered learner base.

Posted by Defense World Staff on Apr 25th, 2026

Shares of Coursera, Inc. (NYSE:COUR – Get Free Report) hit a new 52-week low during mid-day trading on Saturday after Wall Street Zen downgraded the stock from a buy rating to a hold rating. The stock traded as low as $5.00 and last traded at $5.2850, with a volume of 15975919 shares trading hands. The stock had previously closed at $5.97.

Several other brokerages have also recently issued reports on COUR. Royal Bank Of Canada cut their price target on Coursera from $8.00 to $7.00 and set an “outperform” rating for the company in a research note on Friday. Telsey Advisory Group cut their target price on Coursera from $14.00 to $10.00 and set an “outperform” rating for the company in a research note on Friday. BMO Capital Markets reiterated an “outperform” rating and issued a $8.00 price target on shares of Coursera in a research note on Friday, February 6th. UBS Group reiterated a “neutral” rating and issued a $7.00 price target on shares of Coursera in a research note on Friday, February 6th. Finally, KeyCorp dropped their price target on Coursera from $12.00 to $10.00 and set an “overweight” rating for the company in a research note on Friday, February 6th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $9.58.

Read Our Latest Report on Coursera

Insiders Place Their Bets In related news, SVP Alan B. Cardenas sold 9,710 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $5.92, for a total value of $57,483.20. Following the completion of the sale, the senior vice president directly owned 217,876 shares in the company, valued at $1,289,825.92. This represents a 4.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 16.80% of the stock is owned by insiders.

More Coursera News Here are the key news stories impacting Coursera this week:

Positive Sentiment: Record learner growth and strong consumer momentum driven by AI content expansion — supports longer‑term TAM and monetization upside. Read More. Positive Sentiment: Needham reaffirmed a “buy” and $10 price target, signaling some analyst confidence in recovery potential. Read More. Neutral Sentiment: Q1 results: revenue ~$195.7M (≈in line, +9.1% y/y) but EPS of $0.07 missed estimates — mixed fundamentals that leave room for debate on near‑term profit trajectory. Read More. Neutral Sentiment: Guidance: FY revenue range $805M–$815M and Q2 revenue $196M–$200M were generally close to consensus but slightly toward the low side, limiting upside in the near term. Read More. Negative Sentiment: Multiple price‑target cuts: JPMorgan trimmed its PT to $8 (still overweight) and RBC cut to $7 — these marks put downward pressure on sentiment despite some bullish ratings. Read More. Read More. Negative Sentiment: Analyst critique and downgrade citing enterprise churn, shrinking adjusted‑EBITDA margins from increased product & sales investment, and deteriorating fundamentals — raises execution and margin risk. Read More. Negative Sentiment: Wider GAAP loss and a sharp (~88%) drop in free cash flow reported for the quarter, combined with elevated trading volume versus average, amplify near‑term selling pressure. Read More. Institutional Trading of Coursera Institutional investors and hedge funds have recently bought and sold shares of the stock. The Manufacturers Life Insurance Company boosted its position in shares of Coursera by 1.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 70,852 shares of the company’s stock worth $621,000 after purchasing an additional 1,027 shares in the last quarter. Merit Financial Group LLC boosted its stake in Coursera by 9.2% during the 3rd quarter. Merit Financial Group LLC now owns 13,184 shares of the company’s stock valued at $154,000 after purchasing an additional 1,112 shares during the last quarter. ProShare Advisors LLC boosted its stake in Coursera by 10.3% during the 4th quarter. ProShare Advisors LLC now owns 26,096 shares of the company’s stock valued at $192,000 after purchasing an additional 2,439 shares during the last quarter. Diversified Trust Co. boosted its stake in Coursera by 19.0% during the 4th quarter. Diversified Trust Co. now owns 17,691 shares of the company’s stock valued at $130,000 after purchasing an additional 2,824 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Coursera by 2.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 104,795 shares of the company’s stock valued at $698,000 after purchasing an additional 2,847 shares during the last quarter. 89.55% of the stock is currently owned by institutional investors and hedge funds.

Coursera Stock Performance The firm has a market cap of $894.80 million, a price-to-earnings ratio of -13.91 and a beta of 1.35. The business has a 50 day simple moving average of $6.03 and a 200-day simple moving average of $7.21.

Coursera (NYSE:COUR – Get Free Report) last released its quarterly earnings results on Thursday, April 23rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). The company had revenue of $195.70 million for the quarter, compared to analyst estimates of $195.17 million. Coursera had a negative net margin of 8.23% and a negative return on equity of 5.41%. Coursera’s revenue for the quarter was up 9.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.12 EPS. As a group, research analysts anticipate that Coursera, Inc. will post -0.13 earnings per share for the current year.

Coursera Company Profile (Get Free Report)

Coursera, Inc (NYSE:COUR) operates a leading online learning platform that delivers courses, specializations, professional certificates and fully accredited degree programs in collaboration with top universities and industry partners. Founded in 2012 by Stanford University professors Andrew Ng and Daphne Koller, Coursera’s mission is to provide universal access to world-class education and bridge skill gaps in a rapidly evolving job market.

The platform features more than 6,000 offerings created by over 275 academic institutions and corporate entities, spanning fields such as data science, business, technology, health care and the arts.

Featured Stories Five stocks we like better than Coursera Receive News & Ratings for Coursera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coursera and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEHead-To-Head Contrast: US Foods (NYSE:USFD) and Lamb Weston (NYSE:LW)

NEXT HEADLINE »Lithium Stocks To Follow Today – April 23rd

Combined company uniquely positioned to connect skills discovery, development, and verified mastery in a rapidly changing, AI-driven labor market

Enhances ability to build AI-powered, agentic solutions for skills development in the flow of work

Unites a global ecosystem encompassing 290 million learners, 18,000 enterprise customers, 95,000 instructors, and hundreds of university and industry partners

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera, Inc. (NYSE: COUR) today announced the completion of its combination with Udemy, Inc. The transaction strengthens the combined company’s ability to accelerate AI-powered innovation and shape how skills are discovered, developed, and verified at a pivotal moment in global talent transformation.

“The close of this transaction marks the beginning of a new chapter for our combined company. Together, Coursera and Udemy have the scale, the data, and the talent to move faster and build something bold: the world’s most comprehensive skills platform for the AI era,” said Greg Hart, CEO of Coursera. “The need to continuously learn and master new skills has never been greater. Powered by the scale of our combined global ecosystem, we are moving beyond a content catalog to create a more adaptive, intelligent, and agentic skills delivery system — one that more directly connects skills development in the flow of work to real-world outcomes, helping individuals grow their careers and enabling organizations to empower the next generation of talent.”

Creates greater value, impact, and choice

As AI reshapes the skills required for nearly every role, individuals and organizations need a trusted partner to move faster, from identifying emerging skills to building and verifying mastery through a more integrated and complete skills development solution. Coursera and Udemy unite a global ecosystem of 95,000 content creators, encompassing hundreds of world-class educators alongside a dynamic instructor marketplace. This foundation enables the combined company to address the full talent lifecycle, from practical application of skills in the flow of work to high-quality credentials valued for rigor and trust.

Accelerates AI-powered product innovation

The combination expands Coursera’s capacity to invest in AI-native product innovation and agentic solutions, powered by the enhanced scale of its proprietary data and a deeper understanding of how the world learns and the skills employers value most. By connecting learning signals from more than 290 million learners with workforce insights from 18,000 enterprise customers, Coursera will build on the network effects of a unified global platform to accelerate a more connected and data-driven skills economy — linking skills intelligence, verified attainment, and real-world context to deliver more relevant and measurable learning experiences.

Together, Coursera and Udemy are better positioned to accelerate a skills-first future, helping individuals master emerging skills to advance their careers and empowering organizations with the capabilities to develop and deploy talent at the pace of technological change. Additional updates for learners, customers, instructors, and partners will be shared over time on the Coursera Blog at https://blog.coursera.org.

Strengthens financial profile and value creation opportunity

The transaction enhances Coursera’s financial profile, with combined annual revenue of more than $1.5 billion in 2025, structural margin expansion, and increased capacity to invest in product innovation and platform capabilities. As previously announced, the combination is expected to generate meaningful operating efficiencies, with anticipated run-rate annual cost synergies of $115 million within 24 months of closing. The company expects to realize a significant majority of these synergies within the first year. Together, these benefits are expected to support a stronger operating model and increase the company’s ability to invest in its long-term strategy.

The company is also committed to executing a sizable share repurchase program, reflecting Coursera’s confidence in its long-term strategy and the substantial value creation opportunity for the business and its stockholders. The company expects to announce further details regarding its share repurchase program within the next two weeks.

Leadership and Corporate Governance Updates

As previously announced, Greg Hart will continue to serve as Chief Executive Officer, and Mike Foley will continue to serve as Chief Financial Officer. The Board consists of nine directors, including six continuing on the Coursera Board and three formerly on the Udemy Board. Andrew Ng will continue to serve as Chairman of the Board.

Additional information about Coursera’s management team and Board is available at https://investor.coursera.com/governance/management.

Transaction and Closing Details

The transaction was announced on December 17, 2025, and approved by Coursera and Udemy stockholders on April 9, 2026.

Under the terms of the transaction, each outstanding share of Udemy common stock (except for shares owned directly by Coursera, Udemy or Chess Merger Sub, Inc.) was exchanged for 0.800 shares of Coursera common stock. Coursera did not issue fractional shares; former Udemy stockholders received cash in lieu of any fractional share of Coursera common stock to which they otherwise would have been entitled. Former Coursera stockholders own approximately 59% and former Udemy stockholders own approximately 41% of the combined company, on a fully diluted basis.

Coursera will continue to trade under the ticker symbol “COUR” on the New York Stock Exchange. With the closing of the transaction, Udemy’s common stock is being delisted and will no longer trade on NASDAQ.

About Coursera

Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Today, it is one of the largest online learning platforms in the world. Coursera partners with leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including generative AI-powered features like Coach, Role Play, and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. Any statements contained in this press release that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as: “accelerate,” “anticipate,” “believe,” “can,” “continue,” “could,” “demand,” “design,” “estimate,” “expand,” “expect,” “intend,” “may,” “might,” “mission,” “need,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. These forward-looking statements include, but are not limited to, statements regarding the expected benefits of our business combination with Udemy and the outlook for our results of operations and financial condition (including potential synergies) following such business combination; the expansion of our market opportunity; the global demand to embrace new skills; our progress in our growth initiatives; the opportunity to build a more comprehensive and adaptive skills platform designed for the AI era; our commitment to creating more personalized, engaging, and AI-native learning experiences; our initiatives to strengthen our position as a trusted source for verified learning; our mission to provide universal access to world-class learning; the demand for online learning; the strength of our customer and content creator relationships; the demand from learners to use our offerings to master career advancing skills; anticipated features and benefits of our offerings; the anticipated utility of our non-GAAP financial measures; anticipated growth rates; and our financial outlook, future financial and operational performance, and expectations, including our financial outlook for the second quarter of 2026 and full year 2026; among others. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the following: our ability to attract, engage, and retain learners; our ability to increase sales of our offerings; our limited operating history; the relative nascency of online learning solutions and generative AI; risks related to market acceptance and demand for our offerings; our ability to maintain and expand our existing content creator relationships and to develop new partnerships with universities, industry leaders, and subject matter experts; our dependence on the supply of content created by our partners; risks related to our AI innovations and AI generally; risks related to the business combination, including our ability to retain and hire key personnel and maintain relationships with customers, vendors and others with whom we do business as a result of the business combination; the impact of the business combination on our operating results and business generally; the outcome of any legal proceedings related to the business combination; the ability to successfully integrate Coursera’s and Udemy’s operations and business on a timely basis or otherwise in accordance with the standards and obligations applicable to the combined company as a public benefit corporation and as a B Corp.; our ability to implement our plans, forecasts and other expectations with respect to the combined company’s business and realize expected synergies and other benefits of the business combination within the expected timeframe or at all; potential business disruptions arising from the business combination; our ability to compete effectively; adverse impacts on our business and financial condition due to macroeconomic or market conditions; our ability to manage our growth; regulatory and/or policy matters or changes impacting us or our content creators; risks related to intellectual property; cybersecurity and privacy risks and regulations; potential disruptions to our platform; risks related to operations, regulatory, economic, and geopolitical conditions; current and future legal and regulatory matters; the impact of actions to improve operational efficiencies and operating costs; our history of net losses and ability to achieve or sustain profitability; natural disasters, public health crises, or other catastrophic events; and our status as a certified B Corp, as well as the risks and uncertainties discussed in our most recently filed annual and quarterly reports on Forms 10-K and 10-Q and subsequent filings and as detailed from time to time in our SEC filings. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Such forward-looking statements relate only to events as of the date of this press release. We undertake no obligation to update any forward-looking statements except to the extent required by law.

Source Code: COUR-IR

Coursera, Inc. (NYSE: COUR) today announced that its Board of Directors (the “Board”) has approved a share repurchase program under which Coursera is authorized to repurchase up to $500 million of the Company’s common stock. The size of the repurchase program underscores the confidence of Coursera’s leadership in the execution of its strategy, the strength of its future cash flow, and the scale of the global skilling opportunity ahead.

Coursera believes that its enhanced scale following its recent combination with Udemy, Inc., strong financial position, and expected future cash generation, particularly following the achievement of anticipated operating synergies, provide the Company with ample capacity to opportunistically return capital to shareholders, while also investing for durable long-term growth. Coursera expects to fund repurchases with existing cash balances and cash flow from operations.

Repurchases under the program may be made from time to time in the open market, with the amount and timing of repurchases to be determined at Coursera’s discretion, depending on market conditions, corporate considerations, and other factors. Open market repurchases will be structured to occur in accordance with applicable federal securities laws, including the pricing and volume requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company may also, from time to time, enter into trading plans intended to qualify under Rule 10b5-1 of the Exchange Act to facilitate repurchases of its shares under this authorization. This program does not have a fixed expiration date, does not obligate Coursera to acquire any particular amount of common stock, and may be modified, suspended, or discontinued at any time at the discretion of the Board.

About Coursera

Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Coursera partners with leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including AI-powered personalized guide and features, like Role Play and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp. Coursera recently combined with Udemy to create one of the world’s most comprehensive skills development platforms. Together, the Coursera and Udemy platforms reach 290 million learners and 18,000 enterprise customers worldwide.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. Any statements contained in this press release that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as: “accelerate,” “anticipate,” “believe,” “can,” “continue,” “could,” “demand,” “design,” “estimate,” “expand,” “expect,” “intend,” “may,” “might,” “mission,” “need,” “objective,” “ongoing,” “outlook,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. These forward-looking statements include, but are not limited to, statements regarding Coursera leadership’s confidence in the execution of its strategy, strength of its future cash flow, scale of global skilling opportunity ahead, and the substantial value creation opportunity for its shareholders; Coursera’s belief that its enhanced scale in light of its recent business combination with Udemy, Inc. (the “business combination”), strong financial position, and expected future cash generation following achievement of anticipated operating synergies provide Coursera with opportunity to return capital to shareholders and invest in durable long-term growth; the anticipated amount, manner, and timing of execution of the share repurchase program; that Coursera expects to utilize its existing cash and cash equivalents to fund repurchases under the share repurchase program; the expected benefits of the business combination and the outlook for our results of operations and financial condition (including potential synergies) following the business combination; the expansion of our market opportunity; the global demand to embrace new skills; anticipated growth rates; and our financial outlook, future financial and operational performance, and expectations; among others. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the following: our ability to attract, engage, and retain learners; our ability to increase sales of our offerings; our limited operating history; the relative nascency of online learning solutions and generative AI; risks related to market acceptance and demand for our offerings; our ability to maintain and expand our existing content creator relationships and to develop new partnerships with universities, industry leaders, and subject matter experts; our dependence on the supply of content created by our partners; risks related to our AI innovations and AI generally; risks related to the business combination, including our ability to retain and hire key personnel and maintain relationships with customers, vendors, and others with whom we do business as a result of the business combination; the impact of the business combination on our operating results and business generally; the outcome of any legal proceedings related to the business combination; the ability to successfully integrate Coursera’s and Udemy’s operations and business on a timely basis or otherwise in accordance with the standards and obligations applicable to the combined company as a public benefit corporation and as a B Corp.; our ability to implement our plans, forecasts, and other expectations with respect to the combined company’s business and realize expected synergies and other benefits of the business combination within the expected timeframe or at all; potential business disruptions arising from the business combination; our ability to compete effectively; adverse impacts on our business and financial condition due to macroeconomic or market conditions; our ability to manage our growth; regulatory and/or policy matters or changes impacting us or our content creators; risks related to intellectual property; cybersecurity and privacy risks and regulations; potential disruptions to our platform; risks related to operations, regulatory, economic, and geopolitical conditions; current and future legal and regulatory matters; the impact of actions to improve operational efficiencies and operating costs; our history of net losses and ability to achieve or sustain profitability; natural disasters, public health crises, or other catastrophic events; and our status as a certified B Corp, as well as the risks and uncertainties discussed in our most recently filed annual and quarterly reports on Forms 10-K and 10-Q and subsequent filings and as detailed from time to time in our SEC filings. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Such forward-looking statements relate only to events as of the date of this press release. We undertake no obligation to update any forward-looking statements except to the extent required by law.

Source Code: COUR-IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20260518760376/en/

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera, Inc. (NYSE: COUR), a leading global online learning platform, today announced that it will host a supplemental post-merger modeling call on Tuesday, June 23, 2026, at 5:30 a.m. PT / 8:30 a.m. ET. The company’s chief financial officer, Mike Foley, will provide an overview of the combined company’s full year 2026 financial profile following the close of its merger with Udemy on May 11, 2026. Prepared remarks will be followed by an analyst question-and-answer session.

A live webcast and archived replay of the virtual conversation will be available on Coursera’s investor relations website at investor.coursera.com.

Disclosure Information

In compliance with disclosure obligations under Regulation FD, Coursera announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission (“SEC”), press releases, company blog posts, public conference calls, and webcasts, as well as via Coursera’s investor relations website.

About Coursera

Coursera was launched in 2012 by Andrew Ng and Daphne Koller with a mission to provide universal access to world-class learning. Coursera partners with leading university and industry partners to offer a broad catalog of content and credentials, including courses, Specializations, Professional Certificates, and degrees. Coursera’s platform innovations — including AI-powered personalized guide and features, like Role Play and Course Builder, and role-based solutions like Skills Tracks — enable instructors, partners, and companies to deliver scalable, personalized, and verified learning. Institutions worldwide rely on Coursera to upskill and reskill their employees, students, and citizens in high-demand fields such as GenAI, data science, technology, and business, while learners globally turn to Coursera to master the skills they need to advance their careers. Coursera is a Delaware public benefit corporation and a B Corp. Coursera recently combined with Udemy to create one of the world’s most comprehensive skills development platforms. Together, the Coursera and Udemy platforms reach 290 million learners and 18,000 enterprise customers worldwide.

Source Code: COUR-IR

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that its executives will participate at the Bank of America Health Care Conference 2026 at 11:20 a.m. Pacific Time (2:20 p.m Eastern Time) on May 12, 2026 in Las Vegas.

The webcast can also be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcast will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.

About Neurocrine Biosciences
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, endocrine, psychiatric and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)  

NEUROCRINE, the NEUROCRINE BIOSCIENCES Logo, and YOU DESERVE BRAVE SCIENCE are registered trademarks of Neurocrine Biosciences, Inc.

SOURCE Neurocrine Biosciences, Inc.

Neurocrine Biosciences (NBIX - Free Report) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +15.31%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $2.25 per share when it actually produced earnings of $1.88, delivering a surprise of -16.44%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Neurocrine, which belongs to the Zacks Medical - Drugs industry, posted revenues of $814.5 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 9.80%. This compares to year-ago revenues of $572.6 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Neurocrine shares have lost about 5.5% since the beginning of the year versus the S&P 500's gain of 5.2%.

What's Next for Neurocrine?While Neurocrine has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Neurocrine was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $2.03 on $832.71 million in revenues for the coming quarter and $8.47 on $3.47 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Drugs is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Verrica Pharmaceuticals Inc. (VRCA - Free Report) , has yet to report results for the quarter ended March 2026.

This company is expected to post quarterly loss of $0.59 per share in its upcoming report, which represents a year-over-year change of +41%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Verrica Pharmaceuticals Inc.'s revenues are expected to be $4.7 million, up 36.6% from the year-ago quarter.

Neurocrine Biosciences, Inc. (NBIX) Q1 2026 Earnings Call Transcript

Neurocrine Biosciences delivered a strong Q1, with revenue up 42% and healthy growth in Ingrezza and Crenessity. Enhanced sales efforts could drive Ingrezza upside in 2H'26, while Crenessity has a long runway for patient adoption, particularly in adults. The $2.9 billion Soleno acquisition brings Vykat XR, a high-potential offering with clear commercial synergies but significant unknowns around long-term patient uptake and compliance.

Neurocrine Biosciences, Inc. (NBIX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Strengthens Neurocrine's rare disease portfolio with VYKAT™ XR, the first and only approved treatment for hyperphagia in Prader-Willi syndrome Adds recently launched therapy with strong early adoption and meaningful commercial potential , /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the completion of its acquisition of Soleno Therapeutics, Inc., strengthening the company's leadership in endocrinology and rare disease. The acquisition adds VYKAT™ XR (diazoxide choline) tablets, the first and only approved medicine for hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome, to Neurocrine's first-in-class commercial portfolio alongside INGREZZA® (valbenazine) and CRENESSITY® (crinecerfont).

"Today marks an important advancement in Neurocrine's mission to deliver life-changing treatments for patients with significant unmet needs," said Kyle W. Gano, Ph.D., Chief Executive Officer, Neurocrine Biosciences. "We welcome our Soleno colleagues to Neurocrine and share their deep commitment to the Prader-Willi syndrome community, and we look forward to working together to make VYKAT XR available to more patients and their families."

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in gene expression on chromosome 15 that affects about 10,000 patients in the United States. The disease is characterized by neurological, behavioral, and metabolic dysfunction. Its defining feature is hyperphagia, a chronic, life-threatening condition marked by a persistent hunger that drives compulsive food-seeking behavior. Individuals with PWS also commonly experience cognitive impairment and a range of psychiatric and behavioral challenges. Together, these symptoms can severely diminish quality of life for individuals with PWS and their families, with hyperphagia driving significant morbidity and mortality.

Neurocrine initially announced the transaction – representing a total equity value of $2.9 billion – on April 6, 2026.

Transaction Details
Neurocrine completed the cash tender offer through a subsidiary for all the outstanding shares of common stock of Soleno at a purchase price of $53.00 per share, without interest, subject to any applicable withholding taxes.

As of the tender offer expiration at one minute after 11:59 p.m. EDT on May 15, 2026, 46,356,114 shares of Soleno common stock were validly tendered and not validly withdrawn, representing approximately 88.9% of the total number of Soleno's issued and outstanding shares of common stock as of such date and time. In accordance with the terms of the tender offer, all such shares have been accepted for payment.

Following its acceptance of the tendered shares, Neurocrine completed its acquisition of Soleno through the merger of a direct wholly owned subsidiary of Neurocrine with and into Soleno, pursuant to Section 251(h) of the Delaware General Corporation Law on May 18, 2026, with Soleno continuing as the surviving corporation and becoming a direct, wholly owned subsidiary of Neurocrine. All remaining shares of Soleno common stock that were not validly tendered in the tender offer were converted into the right to receive the same $53 per share in cash, without interest, subject to any applicable withholding taxes, that would have been paid had such shares been validly tendered in the tender offer. As of May 18, 2026, Soleno's common stock will no longer be listed or traded on the Nasdaq Capital Market.

Advisors
Goldman Sachs & Co. LLC served as exclusive financial advisor, and Cooley LLP served as legal advisor to Neurocrine. Centerview Partners LLC and Guggenheim Securities, LLC served as financial advisors, and Wilson Sonsini Goodrich & Rosati, Professional Corporation served as legal counsel to Soleno.

About PWS
Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in gene expression on chromosome 15. The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The defining symptom of PWS is hyperphagia, a chronic and life-threatening condition characterized by an intense persistent sensation of hunger accompanied by food preoccupations, an extreme drive to consume food, food-related behavior problems, and a lack of normal satiety, which can severely diminish the quality of life for individuals with PWS and their families. Hyperphagia can lead to significant mortality (e.g., stomach rupture, choking, accidental death due to food-seeking behavior) and longer-term comorbidities such as diabetes, obesity, and cardiovascular disease.

About INGREZZA® (valbenazine)
Please see additional safety information, full Prescribing Information, including Boxed Warning, and Medication Guide.

About CRENESSITY® (crinecerfont)
Please see additional safety information and full Prescribing Information.

About VYKAT XR
VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to U.S. patients.

VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS).

INDICATION
VYKAT XR (diazoxide choline) extended-release tablets is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS).

IMPORTANT SAFETY INFORMATION

Contraindications
Use of VYKAT XR is contraindicated in patients who have a known hypersensitivity to diazoxide, other components of VYKAT XR, or to thiazides.

Warnings and Precautions

Hyperglycemia
Hyperglycemia, including diabetic ketoacidosis, has been reported. Before initiating VYKAT XR, test fasting plasma glucose (FPG) and HbA1c; optimize blood glucose in patients who have hyperglycemia. During treatment, regularly monitor fasting glucose (FPG or fasting blood glucose) and HbA1c. Monitor fasting glucose more frequently during the first few weeks of treatment in patients with risk factors for hyperglycemia.

Risk of Fluid Overload
Edema, including severe reactions associated with fluid overload, has been reported. Monitor for signs or symptoms of edema or fluid overload. VYKAT XR has not been studied in patients with compromised cardiac reserve and should be used with caution in these patients.

Adverse Reactions
The most common adverse reactions (incidence ≥10% and at least 2% greater than placebo) included hypertrichosis, edema, hyperglycemia, and rash.

Please see the full Prescribing Information, including Medication Guide.

About Neurocrine Biosciences
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)

NEUROCRINE, the NEUROCRINE BIOSCIENCES Logo, YOU DESERVE BRAVE SCIENCE, INGREZZA and CRENESSITY are registered trademarks of Neurocrine Biosciences, Inc. SOLENO is a registered trademark of Soleno Therapeutics, Inc. VYKAT is a trademark of Soleno Therapeutics, Inc.

Forward-Looking Statements
This communication contains forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Neurocrine, including statements regarding Neurocrine's acquisition of Soleno, the prospective benefits of the acquisition; Neurocrine's strategy, plans, objectives, expectations (financial or otherwise) and intentions with respect to its future financial results and growth potential, anticipated product portfolio, and development programs; the estimated occurrence of PWS; the estimated U.S. population of PWS patients; and other statements that are not historical facts. The forward-looking statements contained in this communication are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. These statements may contain words such as "anticipate," "believe," "could," "estimate," "expect," "future," "intend," "may," "opportunity," "plan," "potential," "project," "seek," "should," "strategy," "will," "would" or other similar words and expressions indicating future results. Risks that may cause these forward-looking statements to be inaccurate include, without limitation: risks related to Neurocrine's ability to realize the anticipated benefits of the acquisition, including the possibility that the expected benefits from the acquisition will not be realized or will not be realized within the expected time period and that Neurocrine will not be able to integrate Soleno successfully or that such integration may be more difficult, time-consuming or costly than expected; disruption from the acquisition, making it more difficult to conduct business as usual or maintain relationships with employees, customers, suppliers, other business partners or governmental entities; negative effects of the consummation of the acquisition on the market price of Neurocrine's common stock and/or Neurocrine's operating results, including the possibility that if Neurocrine does not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of Neurocrine's common stock could decline; significant transaction and integration costs; unknown or inestimable liabilities; the risk of litigation and/or regulatory actions related to the acquisition; Neurocrine's ability to effectively commercialize VYKAT™ XR (diazoxide choline); the degree and pace of market uptake of VYKAT XR; obtaining and maintaining adequate coverage and reimbursement for Neurocrine's products, including VYKAT XR; the time-consuming and uncertain regulatory approval process; the costly and time-consuming pharmaceutical product development process and the uncertainty of clinical success, including risks related to failure or delays in successfully initiating or completing clinical trials; global economic, financial, and healthcare system disruptions and the current and potential future negative impacts to Neurocrine's business operations and financial results; the sufficiency of Neurocrine's cash flows and capital resources; Neurocrine's ability to achieve targeted or expected future financial performance and results and the uncertainty of future tax, accounting and other provisions and estimates; and other risks and uncertainties affecting Neurocrine, including those described from time to time under the caption "Risk Factors" and elsewhere in Neurocrine's filings and reports with the U.S. Securities and Exchange Commission ("SEC"), including Neurocrine's Quarterly Report on Form 10-Q for the period ended March 31, 2026. Any forward-looking statements are made based on the current beliefs and judgments of Neurocrine's management team, and the reader is cautioned not to rely on any forward-looking statements made by Neurocrine. Except as required by law, Neurocrine does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.

 © 2026 Neurocrine Biosciences, Inc. All Rights Reserved.

SOURCE Neurocrine Biosciences, Inc.

, /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its executives will participate at the following investor conferences:

William Blair 46th Annual Growth Stock Conference. Fireside chat on Tuesday, June 2, 2026 at 10:40 AM CT (11:40 AM ET) in Chicago Goldman Sachs 47th Annual Global Healthcare Conference 2026. Fireside chat on Tuesday, June 9, 2026 at 9:20 AM ET in Miami The webcasts can also be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the webcasts will be available on the website approximately one hour after the conclusion of the event and will be archived for approximately one month.

About Neurocrine Biosciences

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X, Facebook and YouTube. (*in collaboration with AbbVie)  

The NEUROCRINE BIOSCIENCES Logo, NEUROCRINE, and YOU DESERVE BRAVE SCIENCE are registered trademarks of Neurocrine Biosciences, Inc.

SOURCE Neurocrine Biosciences, Inc.